Correction: Phase 2 study of pembrolizumab in patients with advanced rare cancers
Luc Yves Dirix, Eyal Fenig, Rodrigo Ramella Munhoz et al. · Journal for ImmunoTherapy of Cancer · 2020
Naing A, Meric-Bernstam F, Stephen B, et al . Phase 2 study of pembrolizumab in patients with advanced rare cancers. J ImmunoTher Cancer 2020;8:e000347. doi: 10.1136/jitc-2019-000347 In the article titled 'Phase 2 study of pembrolizumab in patients with advanced rare cancers', the author name
Cited by 9 works. doi:10.1136/jitc-2019-000347corr1 Open-access PDF